The A-share CRO concept stocks continued to weaken, with Lingkang Pharmaceutical hitting the daily limit down, Nearshore Protein falling by more than 12%, and Lanwei Medical, Zhaoyan New Drug, and Jinshi Pharmaceutical following suit.
2026-10-27
The A-share CRO concept stocks continued to weaken, with Lingkang Pharmaceutical hitting the daily limit down, Nearshore Protein falling by more than 12%, and Lanwei Medical, Zhaoyan New Drug, and Jinshi Pharmaceutical following suit.